Thomas Deloughery is a Hematology physician affiliated with Oregon Health & Science University. OpenAlex indexes 345 publications with 6,956 citations (h-index 43).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3181 SW Sam Jackson Park Rd
Ohsu L586 Hematology
Portland, OR 972393011
Telephone
503-494-8150Registry record last updated 24 Jan 2018.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20241 payment
- Pharmacosmos Therapeutics Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
48.8%Factor Xa inhibitor25.9%Eliquis79%Fondaparinux Sodium11%Xarelto11%Part D<11 patientsVitamin K antagonist13.3%Warfarin Sodium100%Part D≥66 patients+ 3 more classes in this area
Cancer & immunology
40.7%Kinase inhibitor21%Jakafi73%Sirolimus12%Brukinsa9%Ayvakit7%Part D<11 patientsAntimetabolite14.8%Hydroxyurea100%Part D≥21 patients+ 2 more classes in this area
Nervous system
5.3%Opioid Agonist5.3%Oxycodone Hcl70%Oxycodone-Acetaminophen30%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2000–2001 per NIH RePORTER. The latest:
- EFFECTS OF EXERCISE &HYPOXIA ON BLOOD COAGULATION PILOT STUDY
Oregon Health and Science University
FY2001$172,411M01RR000334 - EFFECTS OF EXERCISE &HYPOXIA ON BLOOD COAGULATION PILOT STUDY
Oregon Health and Science University
FY2001M01RR000334 - EFFECTS OF EXERCISE &HYPOXIA ON BLOOD COAGULATION PILOT STUDY
Oregon Health and Science University
FY2000M01RR000334
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review
Clinical Gastroenterology and Hepatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”